Ausgabe 5/2013
Inhalt (14 Artikel)
Invited Commentary
Is an Aminoglycoside Still Required for the Treatment of Enterococcal Endocarditis?
Donald P. Levine
Invited Commentary
Drug-Resistant Tuberculosis: Pediatric Guidelines
Navaneetha Pandian Poorana Ganga Devi, Soumya Swaminathan
Sepsis and ICU (J Russell, Section Editor)
Noncanonical Nuclear Factor Kappa B (NF-κB) Signaling and Potential for Therapeutics in Sepsis
Simone Thair, James A. Russell
Sepsis and ICU (J Russell, Section Editor)
The Potential for PCR Based Testing to Improve Diagnosis and Treatment of Sepsis
Ngan Lyle, John Boyd
Sepsis and ICU (J Russell, Section Editor)
The Severity of ICU-Acquired Pneumonia
Hugues Marechal, Nathalie Layios, Pierre Damas
SEPSIS AND ICU (J RUSSELL, SECTION EDITOR)
The Surviving Sepsis Campaign’s Revised Sepsis Bundles
Amisha V. Barochia, Xizhong Cui, Peter Q. Eichacker
Sepsis and ICU (J Russell, Section Editor)
Procalcitonin for Antibiotic Treatment in Intensive Care Unit Patients
Nathalie Layios, Bernard Lambermont
Sepsis and ICU (J Russell, Section Editor)
Determinants of Hospital Mortality Among Patients with Sepsis or Septic Shock Receiving Appropriate Antibiotic Treatment
Colleen McEvoy, Marin H. Kollef
Sepsis and ICU (J Russell, Section Editor)
Why Activated Protein C Was Not Successful in Severe Sepsis and Septic Shock: Are We Still Tilting at Windmills?
Peggy S. Lai, B. Taylor Thompson
Skin, Soft Tissue, Bone, and Joint Infections (N Safdar, Section Editor)
Recent Developments in Septic Bursitis
Jennifer A. Hanrahan
Skin, Soft Tissue, Bone, and Joint Infections (N Safdar, Section Editor)
Diagnosis, Prevention, and Treatment of Scabies
Luis Shimose, L. Silvia Munoz-Price
Skin, Soft Tissue, Bone and Joint Infections (N Safdar, Section Editor)
Cutaneous Herpes Zoster
Sharmila Sengupta
Skin, Soft Tissue, Bone, and Joint Infections (N Safdar, Section Editor)
Cutaneous Manifestations of Endemic Mycoses
Jeannina A. Smith, James Riddell IV, Carol A. Kauffman